drugset / Trial / NCT01987167

Defining the Functional and Neuro-Protective Potential of ACTHAR in Acute Optic Neuritis

NCT01987167

NaSingle-groupOpen-labelTreatment

Summary

The goal of the study is to determine the earliest structural changes in the optic nerve during the acute event and during the twelve months of recovery following Acthar treatment.

Timeline

Start
2013-11
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Acthar Peptide 40 iu Subcutaneous

Indications